Ritter Daniher Financial Advisory LLC / DE

Position in IBRX — ImmunityBio, Inc.

CIK 1936603 CINCINNATI, OH

Position in IBRX

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$28,935

+$3,586 QoQ

Shares Held

3,305

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#326

of 401 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ritter Daniher Financial Advisory LLC / DE holds $155,951 across 5 Biotechnology names. IBRX ranks #2 (18.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	255	$126,666
2	IBRX	ImmunityBio, Inc. This page	3,305	$28,935
3	CPRX	Catalyst Pharmaceuticals, Inc.	6	$188
4	HRMY	Harmony Biosciences Holdings, Inc.	4	$145
5	VYGR	Voyager Therapeutics, Inc.	5	$17

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,935	3,305	0.0%	Shares	Sole	2026-07-14
2026-03-31	$25,349	3,305	—	Shares	Sole	2026-05-06
No filing history on record for this holder in this stock.